Abstract
Low levels of dopamine β-hydroxylase (DβH) protein in the plasma or cerebrospinal fluid (CSF) are associated with greater vulnerability to positive psychotic symptoms in several psychiatric disorders. DβH level is a stable, genetically controlled trait. DBH, the locus encoding DβH protein, is the major quantitative trait locus controlling plasma and CSF DβH levels. We therefore hypothesized that DBH variants or haplotypes, associated with low levels of DβH in the plasma, would also associate with greater vulnerability to cocaine-induced paranoia. To test this hypothesis, we first showed that a di-allelic variant, DBH*5′-ins/del, located approximately 3 kb 5′ to the DBH transcriptional start site, significantly associates with plasma DβH activity in European-Americans (n = 66). Linkage disequilibrium analysis of that polymorphism and DBH*444g/a, another di-allelic variant associated with DβH levels, demonstrated that alleles of similar association to DβH levels are in positive disequilibrium. We then estimated DBH haplotype frequencies in cocaine-dependent European Americans rated for cocaine-induced paranoia (n = 45). As predicted, the low-DβH-associated haplotype, Del-a, was significantly more frequent (P = 0.0003) in subjects endorsing cocaine-induced paranoia (n = 29) than in those denying it (n = 16). Comparison to control haplotype frequencies (n = 145 healthy European-Americans) showed that the association predominantly reflected under-representation of Del-a haplotypes in those denying cocaine-induced paranoia. We conclude that: (a) the two DBH polymorphisms we studied are associated with plasma DBH levels; (b) those two polymorphisms are in significant linkage disequilibrium in European Americans, with alleles of similar association to DβH levels in positive disequilibrium; and (c) the haplotype associated with low DBH activity is also associated with cocaine-induced paranoia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Satel SL, Southwick S, Gawin F . Clinical features of cocaine-induced paranoia Am J Psychiatry 1991; 148: 495–499
Brady KT, Lydiard RB, Malcolm R, Ballenger JC . Cocaine-induced psychosis J Clin Psychiatry 1991; 52: 509–511
Rosse RR, Fay-McCarthy M, Collins Jr JP, Alim TN, Deutsch SI . The relationship between cocaine-induced paranoia and compulsive foraging: a preliminary report Addiction 1994; 89: 1097–1104
Satel SL, Edell WS . Cocaine-induced paranoia and psychosis-proneness Am J Psychiatry 1991; 148: 1708–1711
Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies Psychopharmacology 1997; 132: 107–124
Boutros N, Krystal J, Gelernter J . Sensory gating and cocaine induced paranoia Biol Psychiatry 1998; 43: 89S
Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci USA 1997; 94: 587–592
Brady K, Anton R, Ballenger JC, Lydiard B, Adinoff B, Selander J . Cocaine abuse among schizophrenic patients Am J Psychiatry 1990; 147: 1164–1167
Lysaker P, Bell M, Beam-Goulet J, Milstein R . Relationship of positive and negative symptoms to cocaine abuse in schizophrenia J Nerv Mental Dis 1994; 182: 09–112
Gelernter J, Kranzler HR, Satel SL, Rao PA . Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 1994; 11: 195–200
Nurnberger JI, Gershon ES, Simmons S, Ebert M, Kessler LR, Dibble ED et al. Behavioral, biochemical, and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients Psychoneuroendocrinology 1982; 7: 163–176
Lyons MJ, Toomey R, Meyer JM, Green AI, Eisen SA, Goldberg J et al. How do genes influence marijuana use? The role of subjective effects Addiction 1997; 92: 409–417
Cooper JR, Bloom FE, Roth RH . The Biochemical Basis of Neuropharmacology Oxford University Press: New York 1986
Dunnette J, Weinshilboum RM . Human serum dopamine-β-hydroxylase: correlation of enzyme activity with immunoreactive protein in genetically defined samples Am J Hum Genet 1976; 28: 155–166
O'Connor DT, Levine GL, Frigon RP . Homologous radio-immunoassay of human plasma dopamine β-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based upon race, blood pressure and cardiac function J Hypertension 1983; 1: 227–233
O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE et al. Dopamine β-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine β-hydroxylase deficiency Clin Sci 1994; 86: 148–158
Weinshilboum RM . Serum dopamine-β-hydroxylase Pharmacol Rev 1978; 30: 133–166
Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G . Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals—a genetic study J Psychiat Res 1986; 20: 19–29
Goldin LR, Gershon ES, Lake CR, Murphy DL, McGinniss M, Sparkes RS . Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyl transferase (COMT) and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity Am J Hum Genet 1982; 34: 250–262
Wilson AF, Elston RC, Siervogel RM, Tran LD . Linkage of a gene regulating dopamine-β-hydroxylase activity and the ABO blood group locus Am J Hum Genet 1988; 42: 160–166
Wei J, Ramchand CN, Hemmings GP . Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals Hum Genet 1997; 99: 52–55
Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH et al. Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation Hum Genet 1998; 102: 533–540
Sternberg DF, van Kammen DP, Lerner P, Bunney WE . Schizophrenia: dopamine-β-hydroxylase activity and treatment response Science 1982; 216: 1423–1425
van Kammen DP, Kelley ME, Gilbertson MW, Gurklis J, O'Connor DT . CSF dopamine β-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures Am J Psychiatry 1994; 151: 372–378
Meltzer HY, Hyong HW, Carroll BJ, Russo P . Serum dopamine-β-hydroxylase in the affective psychoses and schizophrenia: decreased activity in unipolar psychotically depressed patients Arch Gen Psychiatry 1976; 33: 585–591
Mód L, Rihmer Z, Magyar I, Arató M, Alföldi A, Bagdy G . Serum DBH activity in psychotic vs nonpsychotic unipolar and bipolar depression Psychiatry Res 1986; 19: 331–333
Sapru MK, Rao BSSR, Channabasavanna SM . Serum dopamine-β-hydroxylase activity in clinical subtypes of depression Acta Psychiatr Scand 1989; 80: 474–478
Meyers BS, Alexopoulos GS, Kakuma T, Tirumalesetti F, Gabriele M, Alpert S et al. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression Biol Psychiatry 1999; 45: 448–442
Kobayashi K, Kiuchi K, Ishii A, Kaneda N, Kurosawa Y, Fujita K et al. Human dopamine β-hydoxylase gene: two mRNA types having different 3-terminal regions are produced through alternative polyadenylation Nucl Acids Res 1989; 17: 1089–1102
Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the dopamine β-hydroxylase gene (DBH) Am J Med Genet (Neuropsychiatric Genet) 1997; 74: 374–379
Gelernter J, Kranzler H, Satel SL . No association between D2 dopamine receptor alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- or African Americans Biol Psychiatry 1999; 45: 340–345
Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J . A 19bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus Hum Molec Gen 1992; 1: 286
Long JC, Williams RC, Urbanek M . An E-M algorithm and testing strategy for multiple-locus haplotypes Am J Hum Genet 1995; 56: 799–810
Lewontin RC . On measures of gametic disequilibrium Genetics 1988; 120: 849–852
Sham PC, Curtis D . Monte Carlo tests for associations between disease and alleles at highly polymorphic loci Ann Hum Genet 1995; 59: 97–105
Craig SP, Buckle VJ, Lamaroux A, Malet J, Craig IW . Localization of the human dopamine beta-hydroxylase (DBH) gene to chromosome 9q34 Cytogenet Cell Genet 1988; 48: 48–50
Gelernter J, Gejman PV, Bisighini S, Kidd KK . Sequence tagged site (STS) TaqI RFLP at dopamine β-hydroxylase (DBH) Nucl Acids Res 1991; 19: 1957
Perry SE, Summar L, Phillips JA, Robertson D . Linkage analysis of the human dopamine β-hydroxylase gene Genomics 1991; 10: 493–495
Gelernter J, Goldman D, Risch N . The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal JAMA 1993; 269: 1673–1677
Gejman PV, Gelernter J . Mutational analysis of candidate genes in psychiatric disorders Am J Med. Genet (Neuropsychiatric Genet) 1993; 48: 184–191
Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D et al. DRD2 haplotypes containing the taq I A1 allele: implications for alcoholism research Alcoholism: Clin Exp Res 1996; 20: 697–705
Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ . Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram Addiction 1998; 93: 713–728
Petrakis IL, Carrol KM, Nich C, Gordon L, McCance-Katz EL, Frankforter T et al. Disulfiram treatment for cocaine dependence in methadone maintained opioid addicts Addiction (in press)
Hameedi FA, Rosen MI, McCance-Katz EF, MCMahon TJ, Price LH, Jatlow PI et al. Behavioral, physiological and pharmacological interaction of cocaine and disulfiram Biol Psychiatry 1995; 37: 560–563
McCance-Katz EF, Kosten TR, Jatlow P . Chronic disulfiram treatment effects on intranasal cocaine administration: initial results Biol Psychiatry 1998; 43: 540–543
McCance-Katz EF, Kosten TR, Jatlow P . Disulfiram effects on acute cocaine administration Drug Alc Dep 1998; 52: 27–39
Major LF, Lerner P, Ballenger JC, Brown GL, Goodwin FK, Lovenberg W . Dopamine β-hydroxylase in the cerebrospinal fluid: relationship to disulfiram-induced psychosis Biol Psychiatry 1979; 14: 337–344
Acknowledgements
The authors are grateful to Dr Sally L Satel for subject assessment and collection of DNA samples. Ann Marie Wantroba MS and Harold Landis provided excellent technical assistance. Supported by the US Department of Veterans Affairs Research Program (Research Advisory Group and Presidential Early Career Award for Scientists and Engineers to JFC, Merit Review Award to JG; the VA National Centers for Alcoholism and for Schizophrenia, and the VA Connecticut Mental Illness Research Educational and Clinical Center); NARSAD Young Investigator Awards (JFC and RTM); NIH Grants K02 MH01387 and RO1 AA11330 (JG), P50-AA03510 and K-02-AA00239 (HRK), R-29 DA09573 and K20 DA00216 (EMK), the Yale Mental Health Clinical Research Center (MH30920), the General Clinical Research Center of the University of Connecticut (M01-RR06192), the State of Connecticut Department of Mental Health, a Stanley Foundation Award and a Departmental Research Award, Department of Psychiatry and Human Behavior, Brown University School of Medicine (LHP).
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is a ‘United States Government Work’ paper as defined by the US Copyright Act.
Rights and permissions
About this article
Cite this article
Cubells, J., Kranzler, H., McCance-Katz, E. et al. A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5, 56–63 (2000). https://doi.org/10.1038/sj.mp.4000657
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000657
Keywords
This article is cited by
-
Influence of dopaminergic system gene polymorphisms on mixed amphetamine-type stimulants and opioid dependence in Malaysian Malays
Egyptian Journal of Medical Human Genetics (2019)
-
Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
Neurological Sciences (2019)
-
Association of GA genotype of SNP rs4680 in COMT gene with psoriasis
Archives of Dermatological Research (2019)
-
The dopamine beta-hydroxylase gene polymorphism rs1611114 is associated with schizophrenia in the Chinese Zhuang but not Chinese Han population
Molecular Genetics and Genomics (2016)
-
Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia
Journal of Neural Transmission (2015)